BBH Stock Overview
VanEck ETF Trust - VanEck Biotech ETF is an exchange traded fund launched and managed by Van Eck Associates Corporation.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
VanEck ETF Trust - VanEck Biotech ETF Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$157.33 |
| 52 Week High | US$171.05 |
| 52 Week Low | US$142.51 |
| Beta | 0 |
| 1 Month Change | -4.78% |
| 3 Month Change | -5.84% |
| 1 Year Change | -0.29% |
| 3 Year Change | -16.99% |
| 5 Year Change | 28.74% |
| Change since IPO | 346.33% |
Recent News & Updates
BBH ETF: Buy This ETF At Discounted Price And Hold It For Long Term
Apr 28XBI And IBB: Sell Technology And Buy Biotech, The Only Undervalued Non-Cyclical Growth Sector
Feb 15BBH: Better Than IBB For Covid Exposure Including The Omicron Variant
Nov 30BBH: This ETF Provides Robust Returns To Investors In The Biotech Sector
Sep 26Recent updates
BBH ETF: Buy This ETF At Discounted Price And Hold It For Long Term
Apr 28XBI And IBB: Sell Technology And Buy Biotech, The Only Undervalued Non-Cyclical Growth Sector
Feb 15BBH: Better Than IBB For Covid Exposure Including The Omicron Variant
Nov 30BBH: This ETF Provides Robust Returns To Investors In The Biotech Sector
Sep 26Shareholder Returns
| BBH | US Capital Markets | US Market | |
|---|---|---|---|
| 7D | 2.8% | 2.6% | 1.2% |
| 1Y | -0.3% | 31.6% | 24.9% |
Return vs Industry: BBH underperformed the US Capital Markets industry which returned 31.9% over the past year.
Return vs Market: BBH underperformed the US Market which returned 24.7% over the past year.
Price Volatility
| BBH volatility | |
|---|---|
| BBH Average Weekly Movement | 2.3% |
| Capital Markets Industry Average Movement | 3.5% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: BBH has not had significant price volatility in the past 3 months.
Volatility Over Time: BBH's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | n/a | n/a | www.vaneck.com/us/en/investments/biotech-etf-bbh/ |
VanEck ETF Trust - VanEck Biotech ETF is an exchange traded fund launched and managed by Van Eck Associates Corporation. The fund invests in public equity markets of the United States. It invests in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences, biotechnology sectors.
VanEck ETF Trust - VanEck Biotech ETF Fundamentals Summary
| BBH fundamental statistics | |
|---|---|
| Market cap | US$423.76m |
| Earnings (TTM) | US$0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs BBH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BBH income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$0 |
| Earnings | US$0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did BBH perform over the long term?
See historical performance and comparison